AU2003901579A0 - Therapeutic molecules and methods-3 - Google Patents

Therapeutic molecules and methods-3

Info

Publication number
AU2003901579A0
AU2003901579A0 AU2003901579A AU2003901579A AU2003901579A0 AU 2003901579 A0 AU2003901579 A0 AU 2003901579A0 AU 2003901579 A AU2003901579 A AU 2003901579A AU 2003901579 A AU2003901579 A AU 2003901579A AU 2003901579 A0 AU2003901579 A0 AU 2003901579A0
Authority
AU
Australia
Prior art keywords
methods
therapeutic molecules
therapeutic
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003901579A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortical Pty Ltd
Original Assignee
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monash University filed Critical Monash University
Priority to AU2003901579A priority Critical patent/AU2003901579A0/en
Publication of AU2003901579A0 publication Critical patent/AU2003901579A0/en
Assigned to CORTICAL PTY LTD reassignment CORTICAL PTY LTD Request for Assignment Assignors: MONASH UNIVERSITY
Priority to EP04726068A priority patent/EP1611120A4/en
Priority to CA002521606A priority patent/CA2521606A1/en
Priority to US10/552,595 priority patent/US7863313B2/en
Priority to JP2006504000A priority patent/JP4847314B2/en
Priority to AU2004228069A priority patent/AU2004228069B2/en
Priority to PCT/AU2004/000453 priority patent/WO2004089927A1/en
Priority to ZA200508847A priority patent/ZA200508847B/en
Priority to US12/826,803 priority patent/US20100324001A1/en
Abandoned legal-status Critical Current

Links

AU2003901579A 2003-04-07 2003-04-07 Therapeutic molecules and methods-3 Abandoned AU2003901579A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AU2003901579A AU2003901579A0 (en) 2003-04-07 2003-04-07 Therapeutic molecules and methods-3
PCT/AU2004/000453 WO2004089927A1 (en) 2003-04-07 2004-04-07 Novel methods for the treatment of inflammatory diseases
AU2004228069A AU2004228069B2 (en) 2003-04-07 2004-04-07 Novel methods for the treatment of inflammatory diseases
US10/552,595 US7863313B2 (en) 2003-04-07 2004-04-07 Methods for the treatment of inflammatory diseases
CA002521606A CA2521606A1 (en) 2003-04-07 2004-04-07 Novel methods for the treatment of inflammatory diseases
EP04726068A EP1611120A4 (en) 2003-04-07 2004-04-07 Novel methods for the treatment of inflammatory diseases
JP2006504000A JP4847314B2 (en) 2003-04-07 2004-04-07 Novel methods for treating inflammatory diseases
ZA200508847A ZA200508847B (en) 2003-04-07 2005-11-01 Novel methods for the treatment of inflammatory diseases
US12/826,803 US20100324001A1 (en) 2003-04-07 2010-06-30 Novel Methods for the Treatment of Inflammatory Diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003901579A AU2003901579A0 (en) 2003-04-07 2003-04-07 Therapeutic molecules and methods-3

Publications (1)

Publication Number Publication Date
AU2003901579A0 true AU2003901579A0 (en) 2003-05-01

Family

ID=31500622

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003901579A Abandoned AU2003901579A0 (en) 2003-04-07 2003-04-07 Therapeutic molecules and methods-3

Country Status (2)

Country Link
AU (1) AU2003901579A0 (en)
ZA (1) ZA200508847B (en)

Also Published As

Publication number Publication date
ZA200508847B (en) 2006-10-25

Similar Documents

Publication Publication Date Title
GB2405147B (en) Therapeutic molecules and methods-1
EP1682136A4 (en) Therapeutic compounds and uses thereof
AUPR535101A0 (en) Novel therapeutic molecules
EP1572168A3 (en) Anti-infarction molecules
AU2002327945A1 (en) Human delta-n p73 molecules and uses thereof
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2003237841A1 (en) Pain signaling molecules
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
AU2003901579A0 (en) Therapeutic molecules and methods-3
AUPS283302A0 (en) Therapeutic molecules and methods - 2
AU2003905300A0 (en) Therapeutic molecules
AU2002953267A0 (en) Novel therapeutic molecules and methods relating thereto
AUPS283202A0 (en) Therapeutic molecules and methods - 1
AU2003231937A1 (en) Therapeutic methods
WO2005063292A8 (en) Heh4 molecules and uses thereof
AUPR713201A0 (en) Novel therapeutic molecules and uses therefor
AUPR418101A0 (en) Therapeutic molecules and methods
AUPS161602A0 (en) Novel molecules and uses therefor
AUPR496601A0 (en) Therapeutic molecules and methods - 3
AUPR463401A0 (en) Therapeutic molecules and methods - 2
AUPR421601A0 (en) Therapeutic molecules and methods - 1B
AU2003239717A1 (en) Card-4 molecules and uses thereof
AU2002952216A0 (en) Novel therapeutic molecules

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: CORTICAL PTY LTD

Free format text: FORMER APPLICANT(S): MONASH UNIVERSITY